InSphero AG, signed the definitive agreement to acquire DOPPL SA, including the Sun Bioscience Gri3D ® technology. The acquisition strengthens InSphero’s position as the most comprehensive provider of ...
SCHLIEREN, Switzerland--(BUSINESS WIRE)--The United States Patent and Trademark Office (USPTO) has officially granted InSphero AG full protection of its GravityPLUS™ hanging drop technology. InSphero, ...
SCHLIEREN, ZURICH, SWITZERLAND, February 11, 2026 /EINPresswire.com/ — InSphero AG, the global market leader in 3D cell-based assays and organ-on-chip systems ...
SCHLIEREN, Switzerland and SAN FRANCISCO, Oct. 3, 2019 /PRNewswire/ -- Akero Therapeutics and InSphero AG today announced that Akero has selected InSphero's 3D InSight™ Human Liver Disease Platform to ...
SCHLIEREN, Switzerland--(BUSINESS WIRE)--InSphero AG, the pioneer of 3D cell-based assay technology, today announced that the company is making their proprietary, patented 96- and 384-microwell plates ...
Strategic acquisition strengthens InSphero's global position as the market leader in predictive in vitro modeling and high-content imaging services InSphero AG,a global leader in advanced 3D in vitro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results